ArticleCancer biology & therapy2016

Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer.

Yu Sunakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.